Jeffrey L. Ives
CIK: 0001614096
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ABOS
Acumen Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
About Ives Jeffrey L.
Ives Jeffrey L. (SEC CIK 0001614096) files insider reports with the SEC as Director of Acumen Pharmaceuticals, Inc. (ABOS).
Signal8 holds 2 ownership filings by Ives Jeffrey L., all Form 4s, filed between Jun 5, 2025 and Jun 5, 2026. Those filings report 2 transactions, from Jun 4, 2025 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ives Jeffrey L.'s filings is in NEWTON, MA.
Recent filings by Ives Jeffrey L.
Other insiders filing for Acumen Pharmaceuticals, Inc. (ABOS)
- Porter Derrell, Director
- Fountain Nathan B, Director
- RA CAPITAL MANAGEMENT, L.P., Director
- Drapkin Kimberlee C, Director
- Stalfort John A III, Director
- Golumbeski George, Director